Herd immunity, or network immunity, occurs when a giant portion of the population in a domain is immune to an express disease. If there are enough other people to cause a disease, such as a virus or bacteria, you have nowhere to go.
While not everyone is immune, the organization as a whole is protected. This is because, in general, fewer people can get the infection. Infection rates are reduced and the disease disappears.
Herd immunity protects at-risk populations. These come with young children and others with weak immune systems who can’t build resistance on their own or can’t tolerate a vaccine.
Herd immunity in two ways.
Infection. You can expand resistance naturally. When your body is exposed to a virus or bacteria, it produces antibodies to fight the infection. When you recover, your body keeps those antibodies and uses them to protect against other infections. This is what stopped the Zika virus epidemic in Brazil. Two years after the outbreak, 63% of the population had been exposed to the virus. Network researchers have reached the sweet spot of herd immunity.
Vaccination. Vaccines can also build resistance. They make your body think a virus or bacteria has infected it. You don’t get sick, but your immune system still makes protective antibodies. The next time your body meets that bacteria or virus, it’s ready to fight it off. This is what stopped polio in the United States.
Herd immunity threshold
A network reaches herd immunity (or threshold) at other times for other infections. Each virus or bacterium has its own replication number, or R0. The R0 tells you the average number of other people that a single user infected with the virus can infect if those to whom other people are not yet immune. The higher the R0, the more resilient other people will need to be to achieve herd immunity.
In 2020, researchers estimated that the R0 of COVID-19 was between 2 and 3, which meant that one user could infect 2 or 3 other people. It also meant that between 50% and 67% of the population would have to be resistant before herd immunity kicked in and infection rates began to decline. At the time the Omicron variant was spreading, it was more contagious, with an estimated R0 between 15 and 21, or a threshold of 75 to 80% of the population to be immunized to achieve herd immunity.
Other diseases that spread more easily will result in a steady increase in the percentage of people who will want to get vaccinated to keep infections under control. The threshold for polio is 80 percent and the threshold for highly contagious measles is 95 percent. cent.
The main barrier to herd immunity when COVID began spreading in 2019 was that the virus causing the disease was “new” or new. This meant that it had never inflamed humans before, and they were all at risk of becoming inflamed. There is no immunity to depend on.
There are currently four COVID vaccines that have been administered in more than thirteen billion doses and more than 770 million people have been infected worldwide. But we’re not there to herd immunity with COVID. Reasons why it is difficult to reach the threshold include:
Mutations
COVID has mutated and created new variants including Delta and Omicron. These variants have been more contagious than the original virus, spreading more quickly. To have herd immunity, vaccines have to be created to fight each variant. Because the disease keeps changing, researchers don’t know exactly how long a vaccine is effective in fighting COVID.
Vaccine Effectiveness
The COVID vaccine has been effective in reducing infection rates and making infections less severe in most people. But not enough people have been vaccinated to cause herd immunity. Not everyone who is eligible for the COVID vaccine has earned one due to lack or resolve not to get vaccinated. People with weakened immune systems cannot receive the vaccine. And not everyone has received the vaccines because they are more effective when they receive the necessary dose and boosters.
For COVID, you should get vaccinated and keep up with your boosters so you are protected from any new COVID variants. It’s the best way to protect yourself and others from infection from COVID. And it appears to be the best path to help stop community spread and keep you from getting severe disease.
For other infections, there are a number of steps you can take to prevent or slow the spread, including:
Herd immunity has been effective in slowing or preventing the spread of a number of diseases, including smallpox, measles, and polio. Because the number of people who want to be immune to a disease to reach herd immunity is so high, it’s hard to rely on infection and recovery to reach the threshold. The best tools for creating herd immunity against many diseases are vaccination and practicing smart hygiene.
Can we take advantage of herd immunity against the COVID virus?No country has reached the herd immunity threshold opposite to the COVID virus. The virus mutates quickly, can be transmitted through others who don’t have symptoms, and no one knows exactly how long vaccination protects against infection. For those reasons, classic herd immunity may not be achieved, but COVID may be able to be controlled with annual vaccines, as we do with the flu.
SOURCES:
CDC: “Vaccines and Immunizations: Glossary,” “Frequently Asked Questions — Coronavirus Disease 2019 Basics,” “Understanding How Vaccines Work,” “Polio Elimination in the United States.”
Science Media Center: “Expert Commentary on Herd Immunity. “
Association of Epidemiology and Infection Control Professionals: “Herd Immunity. “
John Hopkins Medicine: “The Immune System.”
mBio: “The highest seroprevalence of the Zika virus in Salvador, in northeastern Brazil, limits the prospects for new epidemics. »
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine: “Critical Immunity Thresholds for Measles Elimination.”
Journal of Travel Medicine: “The reproductive number of COVID-19 is higher compared to SARS coronavirus.”
National Institutes of Health: “NIH Clinical Trial of Experimental COVID-19 Vaccine Begins. “
Imperial College London: “Impact of Non-Pharmaceutical Interventions (NPIs) on Reducing COVID-19 Mortality and Healthcare Demand. “
Journal of Medical Virology: “Coronavirus infections and immune responses.”
Penn State Huck Institutes of Life Sciences: “COVID-19 Frequently Asked Questions: Ask CIDD. “
American Lung Association: “From the Front: Understanding Herd Immunity. “
Virginia Department of Health: “COVID-19 and Influenza Surveillance.”
Journal of the American Medical Association: “What is herd immunity?
Yale Medicine: “Herd Immunity: Will We Ever Get There?”
World Health Organization: “WHO Coronavirus (COVID-19) Dashboard. “
Cureus: “Herd Immunity to Fight Against COVID-19: A Narrative Review.”
UK Governor: “Living safely with respiratory infections, COVID-19. “
National Foundation for Infectious Diseases: “Infectious Diseases. “
Johns Hopkins Bloomberg School of Public Health: “Rethinking Herd Immunity and the End of the Covid-19 Response. »
The Journal of Infectious Diseases: “The concept of traditional herd immunity probably doesn’t apply to COVID-19. »
Here’s what you want to know.
Does it linger after weeks or months? Know the facts.
From headaches to mood swings, symptoms you should be aware of.
© 2005 – 2023 WebMD LLC, an Internet logo company. All Rights Reserved. WebMD provides medical advice, diagnosis, or treatment. Learn more.